| 中印制药产业竞争力比较研究 |
| |
| 引用本文： | 李建青,黄泰康. 中印制药产业竞争力比较研究[J]. 中国药房, 2007, 18(31): 2405-2407 |
| |
| 作者姓名： | 李建青 黄泰康 |
| |
| 作者单位： | 1. 沈阳药科大学现代社会药学研究中心,沈阳市,110016
2. 国家食品药品监督管理局,北京市,100061 |
| |
| 摘 要： | 目的:为我国制药产业提高国际竞争力提供参考。方法:提炼决定制药产业国际竞争力的主要因素,对中印制药产业的国际竞争力分别进行SWOT(优势、劣势、机会、威胁)分析。结果:印度制药产业在国际新药注册、质量认证和人才战略等方面远远领先于我国。结论:我国制药产业可以借鉴印度制药产业的成功经验,确定适合自己的发展战略。
|
| 关 键 词： | 中国 印度 制药产业 竞争力 SWOT分析 |
| 文章编号： | 1001-0408（2007）31-2405-03 |
| 收稿时间： | 2007-04-05 |
| 修稿时间： | 2007-05-18 |
China vs. India in Competitiveness of Pharmaceutical Industry |
| |
| LI Jianqing,HUANG Taikang. China vs. India in Competitiveness of Pharmaceutical Industry[J]. China Pharmacy, 2007, 18(31): 2405-2407 |
| |
| Authors: | LI Jianqing HUANG Taikang |
| |
| Abstract: | OBJECTIVE: To provide references for Chinese pharmaceutical industry in improving international competitiveness. METHODS: The main decisive factors of the international competitiveness in pharmaceutical industry were obtained and SWOT analysis of international competitiveness in pharmaceutical industries of China and India were analyzed. RESULTS: Indian pharmaceutical industry was well ahead of its Chinese counterpart in new drug registration, quality certification, and human resource etc. CONCLUSION: Chinese pharmaceutical industry may draw the successive experience from its Indian counterpart to determine its own suitable development strategy. |
| |
| Keywords: | China India Pharmaceutical industry Competitiveness SWOT analysis |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
